PGCM
EVH icon

Prescott Group Capital Management’s Evolent Health EVH Stock Holding History

Prescott Group Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-152,251
Closed -$1.71M – 261
2024
Q4 		$1.71M Buy
+152,251
New +$2.68M 0.23% 129
2023
Q2 		– Sell
-20,000
Closed -$649K – 165
2023
Q1 		$649K Hold
20,000
– – 0.15% 137
2022
Q4 		$562K Hold
20,000
– – 0.12% 144
2022
Q3 		$719K Buy
+20,000
New +$705K 0.22% 96

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Prescott Group Capital Management's EVH Position: Q1 2025 in Review

Prescott Group Capital Management sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 152,251 shares — an estimated $1.71M sold.

Prescott Group Capital Management first reported a position in EVH in Q3 2022 and held it in 4 quarters. The position peaked at $1.71M in Q4 2024. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Prescott Group Capital Management reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Prescott Group Capital Management sold 152,251 Evolent Health shares in Q1 2025, an estimated $1.71M.
  • Prescott Group Capital Management first reported a position in Evolent Health in Q3 2022 and held it in 4 quarters.
  • Prescott Group Capital Management's Evolent Health position peaked at $1.71M in Q4 2024.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Prescott Group Capital Management's 13F filing for Q1 2025, filed 7 May 2025.